Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$628M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$608M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$518M |
| 4 |
Intel
INTC
|
+$172M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$565M |
| 2 |
Amazon
AMZN
|
+$437M |
| 3 |
Microsoft
MSFT
|
+$405M |
| 4 |
NVIDIA
NVDA
|
+$226M |
| 5 |
LyondellBasell Industries
LYB
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.07% |
| 2 | Financials | 5.69% |
| 3 | Healthcare | 5.49% |
| 4 | Consumer Discretionary | 4.41% |
| 5 | Industrials | 3.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Encore Capital Group
ECPG
$2.04B
| $792K | ﹤0.01% |
13,709
-87,650
| -86% | -$5.19M |
|
|
EXAS
2827
CALL
DELISTED
Exact Sciences
EXAS
| $788K | ﹤0.01% |
+20,000
| New | +$1.07M |
|
|
EXAS
2828
PUT
DELISTED
Exact Sciences
EXAS
| $788K | ﹤0.01% |
+20,000
| New | +$1.07M |
|
2829
Enpro
NPO
$6.69B
| $788K | ﹤0.01% |
9,629
-8,883
| -48% | -$828K |
|
2830
CALL
Cytokinetics
CYTK
$10.5B
| $786K | ﹤0.01% |
+20,000
| New | +$805K |
|
|
2831
PUT
Cytokinetics
CYTK
$10.5B
| $786K | ﹤0.01% |
+20,000
| New | +$805K |
|
2832
Cinemark Holdings
CNK
$4.24B
| $785K | ﹤0.01% |
52,246
-43,082
| -45% | -$682K |
|
2833
Middlesex Water
MSEX
$1.07B
| $785K | ﹤0.01% |
8,953
-8,807
| -50% | -$789K |
|
2834
Graham Holdings Company
GHC
$5.17B
| $784K | ﹤0.01% |
1,383
+159
| +13% | +$94.6K |
|
2835
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.56B
| $783K | ﹤0.01% |
19,183
+12,178
| +174% | +$543K |
|
2836
National Presto Industries
NPK
$873M
| $775K | ﹤0.01% |
11,802
-2,501
| -17% | -$177K |
|
2837
Oxford Industries
OXM
$570M
| $775K | ﹤0.01% |
8,748
-6,797
| -44% | -$610K |
|
|
KDNY
2838
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $775K | ﹤0.01% |
44,297
+29,457
| +198% | +$462K |
|
|
CBAY
2839
DELISTED
Cymabay Therapeutics
CBAY
| $774K | ﹤0.01% |
262,404
+256,894
| +4,662% | +$614K |
|
|
VIVO
2840
DELISTED
Meridian Bioscience Inc
VIVO
| $773K | ﹤0.01% |
25,409
-23,426
| -48% | -$634K |
|
2841
iShares US Energy ETF
IYE
$1.75B
| $771K | ﹤0.01% |
20,231
-3,701
| -15% | -$157K |
|
2842
GATX Corp
GATX
$6.32B
| $770K | ﹤0.01% |
8,182
+2,023
| +33% | +$216K |
|
|
ISAA
2843
DELISTED
Iron Spark I Inc. Class A Common Stock
ISAA
| $770K | ﹤0.01% |
78,146
| – | – |
|
2844
Invesco DB US Dollar Index Bullish Fund
UUP
$420M
| $769K | ﹤0.01% |
27,500
-11,900
| -30% | -$326K |
|
|
MAXN
2845
DELISTED
Maxeon Solar Technologies
MAXN
| $767K | ﹤0.01% |
577
-63
| -10% | -$78K |
|
2846
Sally Beauty Holdings
SBH
$1.42B
| $766K | ﹤0.01% |
64,262
-42,657
| -40% | -$620K |
|
2847
Northwest Bancshares
NWBI
$2.3B
| $765K | ﹤0.01% |
59,740
-53,428
| -47% | -$681K |
|
2848
Knowles
KN
$3.17B
| $762K | ﹤0.01% |
44,022
-38,413
| -47% | -$722K |
|
2849
Methode Electronics
MEI
$492M
| $762K | ﹤0.01% |
20,572
-16,782
| -45% | -$724K |
|
|
POLY
2850
DELISTED
Plantronics, Inc.
POLY
| $762K | ﹤0.01% |
19,220
-35,302
| -65% | -$1.4M |
|
Similar funds
Citigroup's Q2 2022 Portfolio in Review
As of Q2 2022, Citigroup held 6,955 positions worth $134B, down 18% from $165B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Citigroup's Q2 2022 filing shows 507 new, 2,096 increased, 2,889 reduced and 579 closed positions. Its largest new stake was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M. The largest sale was iShares Russell 2000 ETF, an estimated $565M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2022 buy was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M.
- Citigroup added most to Invesco QQQ Trust in Q2 2022, an estimated $628M increase.
- Citigroup's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $565M.
- Citigroup fully exited People's United Financial Inc in Q2 2022, selling an estimated $103M.
- Citigroup's ten largest holdings make up 29% of its $134B portfolio in Q2 2022.
- Citigroup opened 507 new positions and closed 579 in Q2 2022.
- Citigroup's portfolio value fell 18% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.